Cargando…
Trastuzumab induces PUMA‐dependent apoptosis and inhibits tumor growth in gastric cancer
Gastric cancer (GC) is one of the most prevalent cancers worldwide. Trastuzumab has been approved for the treatment of metastatic GC, gastroesophageal junction cancer, and breast cancer. However, the mechanisms involved in trastuzumab‐induced GC cell apoptosis remain largely unknown. In this study,...
Autores principales: | Luo, Linghe, Liu, Haiyan, Xi, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275257/ https://www.ncbi.nlm.nih.gov/pubmed/30524942 http://dx.doi.org/10.1002/2211-5463.12522 |
Ejemplares similares
-
Retraction statement: Luo L, Liu H and Xi Q (2018) Trastuzumab induces PUMA‐dependent apoptosis and inhibits tumor growth in gastric cancer. FEBS Open Bio 8, 1911–1919.
Publicado: (2023) -
Idelalisib induces PUMA-dependent apoptosis in colon cancer cells
por: Yang, Shida, et al.
Publicado: (2016) -
BRD9 inhibition promotes PUMA-dependent apoptosis and augments the effect of imatinib in gastrointestinal stromal tumors
por: Mu, Jianfeng, et al.
Publicado: (2021) -
PUMA and Bax-induced Autophagy Contributes to Apoptosis
por: Yee, Karen S., et al.
Publicado: (2009) -
Caspase-9 mediates Puma activation in UCN-01-induced apoptosis
por: Nie, C, et al.
Publicado: (2014)